◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

ST中珠

ST中珠
Loading...
Key Metrics
Market Cap
5.7B ($824.9M)
P/E Ratio
N/A
P/B Ratio
N/A
Revenue
521.0M
Net Income
-625.0M
Gross Margin
N/A
Op. Margin
-120.7%
Net Margin
-120.0%
ROE
-35.9%
ROA
-29.5%
D/E
0.22
Dividend Yield
N/A
EPS
-0.31
Current Ratio
3.69
Price History
Company Info
IndustryQ84卫生
Market SegmentMain Board
CurrencyCNY
Fiscal Year2024
Business Overview

Zhongzhu Healthcare Holding Co.,Ltd engages in the research and development, production, and sale of drugs in China. The company offers ophthalmology drugs, including Pearl eye drops, Sodium Cromolyn eye drops, Acyclovir eye drops, Hydroxybenzone Hydrochloride eye drops, Acyclovir dispersible tablets, and Gatifloxacin tablets; and products related to tumor treatment. It is also involved in production and sales of products of hepatest ultrasonic liver cirrhosis detector, infusion heater, and Moon God whole body gamma knife. In addition, the company develops 1.1-class chemical drug Leonurine (SC...

Peers
工商银行
601398
2.7T
P/E: 7.6
建设银行
601939
2.5T
P/E: 7.2
农业银行
601288
2.4T
P/E: 8.7
中国海油
600938
2.0T
P/E: 16.2
宁德时代
300750
1.9T
P/E: 25.6
贵州茅台
600519
1.8T
P/E: 20.1
中国银行
601988
1.8T
P/E: 7.3
中国人寿
601628
1.2T
P/E: 6.9
Financial Statements
Loading financials...
Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About ST中珠

Zhongzhu Healthcare Holding Co.,Ltd engages in the research and development, production, and sale of drugs in China. The company offers ophthalmology drugs, including Pearl eye drops, Sodium Cromolyn eye drops, Acyclovir eye drops, Hydroxybenzone Hydrochloride eye drops, Acyclovir dispersible tablets, and Gatifloxacin tablets; and products related to tumor treatment. It is also involved in production and sales of products of hepatest ultrasonic liver cirrhosis detector, infusion heater, and Moon God whole body gamma knife. In addition, the company develops 1.1-class chemical drug Leonurine (SCM-198) project with the effect of lowering blood lipids and preventing and treating stroke; and genistein capsules for the treatment of osteoporosis. Further, it engages in residential real estate development; business management; hospital investment management; technology promotion and application services; research and experimental development; special equipment manufacturing industry; and financial leasing business. Zhongzhu Healthcare Holding Co.,Ltd was formerly known as Zhongzhu Holding Co., Ltd. and changed its name to Zhongzhu Healthcare Holding Co., Ltd in June 2016. The company was founded in 1970 and is headquartered in Zhuhai, China.


Ticker600568
ExchangeSSE
Sector证监会行业分类
IndustryQ84卫生
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...